Edit |   |
---|---|
Antigenic Specificity | FCER2, Human (Lumiliximab biosimilar) |
Clone | Lumiliximab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IP, IF, FuncS, FCM, Neut, ELISA, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human FCER2 Recombinant Antibody. Lumiliximab is an IgG1k monoclonal antibody that targets CD23. It acts as an immunomodulator and was awarded orphan drug status and fast track designation by the FDA. |
Immunogen | n/a |
Other Names | Anti-FCER2 Recombinant Antibody, Research Grade Lumiliximab, Anti-Human FCER2 Recombinant Antibody, IDEC-152, P5E8, Antibody Drug Analogues, Monoclonal Antibody, YR1096, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 357613-86-6 |
Catalog # | YR1096 |
Price | please inquire |
Order / More Info | FCER2, Human (Lumiliximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |